Cargando…
PULMONARY ASPERGILLOSIS POST-TOCILIZUMAB TREATMENT IN A PATIENT WITH COVID-19 PNEUMONIA
Autores principales: | GIDWANI, VIPUL, CHAUHAN, SHAYLIKA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548780/ http://dx.doi.org/10.1016/j.chest.2022.08.296 |
Ejemplares similares
-
PREVOTELLA BIVIA BACTEREMIA POST TOCILIZUMAB IN A PATIENT WITH SEVERE COVID-19 PNEUMONIA
por: AIYANYOR, ALFRED, et al.
Publicado: (2021) -
POST-COVID-19 ASPERGILLOSIS
por: BAIG, MARIA HAIDER
Publicado: (2022) -
POST-ACUTE COVID-19 SUBACUTE INVASIVE PULMONARY ASPERGILLOSIS WITH MASSIVE HEMOPTYSIS
por: KULKARNI, V., et al.
Publicado: (2022) -
CONCOMITANT PULMONARY MUCORMYCOSIS AND PULMONARY ASPERGILLOSIS IN A YOUNG PATIENT WITH COVID-19
por: FELDMAN, ERICA, et al.
Publicado: (2021) -
A CASE OF COVID-19-ASSOCIATED PULMONARY ASPERGILLOSIS
por: LIN, KAIQING, et al.
Publicado: (2022)